Cannabis Extract Induces Melanoma Cell Death

A concentrated cannabis extract known as PHEC-66 has shown potential to induce programmed cell death in melanoma cells, offering a new avenue for treating the deadly skin cancer. Developed by MGC Pharmaceuticals in Australia, the extract has demonstrated the ability to halt cell proliferation and elevate reactive oxygen species levels in melanoma cells. While promising, further research in living animal models and clinical trials in humans are needed to validate these findings and determine the appropriate dosage and application of the extract. This study adds to a growing body of research on the potential of cannabis compounds in fighting various types of cancer, highlighting the need for continued investigation into their medicinal properties.